Market Overview

Hearing UBS Says Endo Likely to be Sold at $40+/share.

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: UBSAnalyst Color News Rumors M&A Analyst Ratings Movers

 

Most Popular

Related Articles (ENDP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters